26(top 2%)
papers
961(top 2%)
citations
11(top 2%)
h-index
21(top 2%)
g-index
27
all documents
1.0K
doc citations
462
citing journals

Top Articles

#TitleJournalYearCitations
1Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre-and Post-tumor Resection for Recurrent GBMMolecular Therapy2009346
2Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solutionKidney International2002242
3Association between Vancomycin-Resistant Enterococci Bacteremia and Ceftriaxone UsageInfection Control and Hospital Epidemiology201267
4Pneumocystis pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)‐infected and HIV‐uninfected personsTransplant Infectious Disease201265
5Initial management of candidemia at an academic medical center: Evaluation of the IDSA guidelinesDiagnostic Microbiology and Infectious Disease200550
6The Cost of Transplant Immunosuppressant Therapy: Is This Sustainable?Current Transplantation Reports201546
7Observational study of the epidemiology and outcomes of vancomycin-resistantEnterococcusbacteraemia treated with newer antimicrobial agentsEpidemiology and Infection201141
8Metabolic Complications of Total Parenteral Nutrition: Effects of a Nutrition Support ServiceJournal of Parenteral and Enteral Nutrition199637
9Comparative Effectiveness of Vedolizumab vs. Infliximab Induction Therapy in Ulcerative Colitis: Experience of a Real-World Cohort at a Tertiary Inflammatory Bowel Disease CenterGastroenterology Research201831
10Survey of the Stocking of Poison Antidotes in Alabama HospitalsSouthern Medical Journal199917
11A Continuous Veno-Venous Hemofiltration Protocol with Anticoagulant Citrate Dextrose Formula a and a Calcium-Containing Replacement FluidInternational Journal of Artificial Organs201414
12Total and out-of-pocket costs for PARP inhibitors among insured ovarian cancer patientsGynecologic Oncology202111
13The financial burden of PARP inhibitors on patients, payors, and financial assistance programs: Who bears the cost?Gynecologic Oncology202110
14Is memantine a potential therapeutic for Rett syndrome?Frontiers in Neuroscience20136
15Collaborative cardiovascular management of patients with chronic myeloid leukemia on tyrosine kinase inhibitorsVascular Medicine20206
16Dismal survival outcomes of patients with acute myeloid leukemia after failure of venetoclax with hypomethylating agentsLeukemia and Lymphoma20225
17Detection of rarely identified multiple mutations in MECP2 gene do not contribute to enhanced severity in rett syndromeAmerican Journal of Medical Genetics, Part A20134
18Letter to the Editor: “Use of inhaled epoprostenol with high flow nasal oxygen in non-intubated patients with severe COVID-19”Journal of Critical Care20224
19Increasing Prevalence of Pediatric Community-acquired UTI by Extended Spectrum β-Lactamase-producing E. coli: Cause for ConcernPediatric Infectious Disease Journal20232
20Outsourcing: A success storyAmerican Journal of Health-System Pharmacy19971
21Myocardial ischemia with fluorouracil and floxuridine therapyClinical Pharmacy19871
22Superiority of fixed-dose warfarin for chronic anticoagulationJournal of Stroke and Cerebrovascular Diseases20040
23Improvement of Gram-negative Susceptibility to Fluoroquinolones After Implementation of a Pre-Authorization Policy for Fluoroquinolone Use: A Decade-Long ExperienceOpen Forum Infectious Diseases20170
24AML-430: Utility of End-of-Induction Bone Marrow Biopsy in APL Patients Treated with ATRA/ATO RegimenClinical Lymphoma, Myeloma and Leukemia20210
25Poster: AML-430: Utility of End-of-Induction Bone Marrow Biopsy in APL Patients Treated with ATRA/ATO RegimenClinical Lymphoma, Myeloma and Leukemia20210
26Survival outcomes of patients with relapsed or refractory acute myeloid leukemia after venetoclax combined with hypomethylating agents.Journal of Clinical Oncology20220